Phathom Pharma Files DEF 14A on Exec Comp
Ticker: PHAT · Form: DEF 14A · Filed: Apr 23, 2025 · CIK: 1783183
| Field | Detail |
|---|---|
| Company | Phathom Pharmaceuticals, Inc. (PHAT) |
| Form Type | DEF 14A |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, equity-awards, sec-filing
TL;DR
Phathom Pharma's DEF 14A shows exec comp details & equity award valuations for 2023-2024.
AI Summary
Phathom Pharmaceuticals, Inc. filed a DEF 14A on April 23, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and equity awards granted in prior years, with changes in fair value reported for 2023 and 2024. The company is based in Florham Park, NJ.
Why It Matters
This filing provides transparency into how Phathom Pharmaceuticals compensates its top executives and the valuation of equity awards, which can influence investor perception and employee morale.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and does not indicate any immediate financial distress or significant operational changes.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for executive compensation details.)
- 2023 — Prior Year (Comparative data for equity award valuations.)
Key Players & Entities
- Phathom Pharmaceuticals, Inc. (company) — Filer
- Florham Park, NJ (location) — Business Address
FAQ
What is the primary purpose of this DEF 14A filing for Phathom Pharmaceuticals?
The primary purpose is to disclose information regarding executive compensation, including changes in the fair value of outstanding equity awards granted in prior years for the fiscal years 2023 and 2024.
When was this DEF 14A filing submitted to the SEC?
This filing was submitted on April 23, 2025.
What is the fiscal year end for Phathom Pharmaceuticals?
The fiscal year end for Phathom Pharmaceuticals is December 31.
Where is Phathom Pharmaceuticals headquartered?
Phathom Pharmaceuticals, Inc. is located at 100 Campus Drive, Suite 102, Florham Park, NJ 07932.
What specific types of compensation data are detailed in the filing for the covered years?
The filing details changes in the fair value of outstanding and unvested equity awards granted in prior years, as well as equity awards granted in the covered years, for both non-personnel and personnel members.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 23, 2025 regarding Phathom Pharmaceuticals, Inc. (PHAT).